New York Gov. Andrew Cuomo Raises More Than $1 Million at First Fundraiser Since Investigations

More than 150 guests, including Democratic Party officials, labor leaders and real-estate developers, attended the $10,000-a-head event

Clinical Trial

Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis

G Ristori et al. Neurology. .

Abstract

We studied the effect of Bacille Calmette-Guerin (BCG) vaccine as an immunomodulator in MS. According to the guidelines for clinical trials in MS, a single crossover, MRI-monitored trial was performed in 14 patients with relapsing-remitting MS. After treatment, MRI activity was significantly reduced. No major adverse effects were reported. Adjuvant therapy with BCG vaccine was safe and merits study in MS.

Comment in